The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score

The Psoriasis Area and Severity Index (PASI) is the most widely used clinical measure in clinical trials to assess disease severity of plaque psoriasis. However, the PASI is not a precise measure of severity with less precision when the regional area of involvement is < 10% of the BSA of a specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, Kim A., Lebwohl, Mark G., Kircik, Leon H., Pariser, David M., Strober, Bruce, Krueger, Gerald G., Berk, David R., Navale, Lynn, Higham, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322185/
https://www.ncbi.nlm.nih.gov/pubmed/34236691
http://dx.doi.org/10.1007/s13555-021-00572-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322185/
https://www.ncbi.nlm.nih.gov/pubmed/34236691
http://dx.doi.org/10.1007/s13555-021-00572-2

Ejemplares similares